The introduction of nicotinamide for a nicotine alternative in e-cigarette and smokeless merchandise signifies a substantial regulatory obstacle for that FDA. Nicotinamide doesn't have nicotinic receptor agonist action and is understood to act as a sedative at higher dosages6. The promises created by Nicotine River, ECBlend, and other vendors that